Literature DB >> 17982023

Cutting edge: identification of a pre-ligand assembly domain (PLAD) and ligand binding site in the IL-17 receptor.

Jill M Kramer1, Walter Hanel, Fang Shen, Nilgun Isik, James P Malone, Amarnath Maitra, Wade Sigurdson, David Swart, Joel Tocker, Tian Jin, Sarah L Gaffen.   

Abstract

IL-17 is the hallmark cytokine of the newly described "Th17" lymphocyte population. The composition, subunit dynamics, and ligand contacts of the IL-17 receptor are poorly defined. We previously demonstrated that the IL-17RA subunit oligomerizes in the membrane without a ligand. In this study, computational modeling identified two fibronectin-III-like (FN) domains in IL-17RA connected by a nonstructured linker, which we predicted to mediate homotypic interactions. In yeast two-hybrid, the membrane-proximal FN domain (FN2), but not the membrane-distal domain (FN1), formed homomeric interactions. The ability of FN2 to drive ligand-independent multimerization was verified by coimmunoprecipitation and fluorescence resonance energy transfer microscopy. Thus, FN2 constitutes a "pre-ligand assembly domain" (PLAD). Further studies indicated that the FN2 linker domain contains the IL-17 binding site, which was never mapped. However, the FN1 domain is also required for high affinity interactions with IL-17. Therefore, although the PLAD is located entirely within FN2, effective ligand binding also involves contributions from the linker and FN1.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17982023      PMCID: PMC2973996          DOI: 10.4049/jimmunol.179.10.6379

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  33 in total

1.  A domain in TNF receptors that mediates ligand-independent receptor assembly and signaling.

Authors:  F K Chan; H J Chun; L Zheng; R M Siegel; K L Bui; M J Lenardo
Journal:  Science       Date:  2000-06-30       Impact factor: 47.728

2.  Fas preassociation required for apoptosis signaling and dominant inhibition by pathogenic mutations.

Authors:  R M Siegel; J K Frederiksen; D A Zacharias; F K Chan; M Johnson; D Lynch; R Y Tsien; M J Lenardo
Journal:  Science       Date:  2000-06-30       Impact factor: 47.728

Review 3.  Signaling domains of the interleukin 2 receptor.

Authors:  S L Gaffen
Journal:  Cytokine       Date:  2001-04-21       Impact factor: 3.861

4.  Ligand-induced conformational changes allosterically activate Toll-like receptor 9.

Authors:  Eicke Latz; Anjali Verma; Alberto Visintin; Mei Gong; Cherilyn M Sirois; Dionne C G Klein; Brian G Monks; C James McKnight; Marc S Lamphier; W Paul Duprex; Terje Espevik; Douglas T Golenbock
Journal:  Nat Immunol       Date:  2007-06-17       Impact factor: 25.606

5.  Structural design and molecular evolution of a cytokine receptor superfamily.

Authors:  J F Bazan
Journal:  Proc Natl Acad Sci U S A       Date:  1990-09       Impact factor: 11.205

Review 6.  Fibronectin and its receptors.

Authors:  E Ruoslahti
Journal:  Annu Rev Biochem       Date:  1988       Impact factor: 23.643

Review 7.  The pre-ligand binding assembly domain: a potential target of inhibition of tumour necrosis factor receptor function.

Authors:  F K Chan
Journal:  Ann Rheum Dis       Date:  2000-11       Impact factor: 19.103

8.  Ligand-independent oligomerization of cell-surface erythropoietin receptor is mediated by the transmembrane domain.

Authors:  S N Constantinescu; T Keren; M Socolovsky; H Nam ; Y I Henis; H F Lodish
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-10       Impact factor: 11.205

9.  Crystallographic evidence for preformed dimers of erythropoietin receptor before ligand activation.

Authors:  O Livnah; E A Stura; S A Middleton; D L Johnson; L K Jolliffe; I A Wilson
Journal:  Science       Date:  1999-02-12       Impact factor: 47.728

10.  Interleukin-6 signal transducer gp130 has specific binding sites for different cytokines as determined by antagonistic and agonistic anti-gp130 monoclonal antibodies.

Authors:  J Wijdenes; P C Heinrich; G Müller-Newen; C Roche; Z J Gu; C Clément; B Klein
Journal:  Eur J Immunol       Date:  1995-12       Impact factor: 5.532

View more
  18 in total

Review 1.  Piecing it together: Unraveling the elusive structure-function relationship in single-pass membrane receptors.

Authors:  Christopher C Valley; Andrew K Lewis; Jonathan N Sachs
Journal:  Biochim Biophys Acta Biomembr       Date:  2017-01-12       Impact factor: 3.747

Review 2.  Structure-function relationships in the IL-17 receptor: implications for signal transduction and therapy.

Authors:  Fang Shen; Sarah L Gaffen
Journal:  Cytokine       Date:  2008-01-04       Impact factor: 3.861

Review 3.  Role of IL-17 in psoriasis and psoriatic arthritis.

Authors:  Siba P Raychaudhuri
Journal:  Clin Rev Allergy Immunol       Date:  2013-04       Impact factor: 8.667

4.  Evolution of the IL17 receptor family in chordates: a new subfamily IL17REL.

Authors:  Baojun Wu; Meng Jin; Yi Zhang; Tiandi Wei; Zengliang Bai
Journal:  Immunogenetics       Date:  2011-07-06       Impact factor: 2.846

5.  Paneth cell-derived interleukin-17A causes multiorgan dysfunction after hepatic ischemia and reperfusion injury.

Authors:  Sang Won Park; Mihwa Kim; Kevin M Brown; Vivette D D'Agati; H Thomas Lee
Journal:  Hepatology       Date:  2011-05       Impact factor: 17.425

Review 6.  IL-17RC: a partner in IL-17 signaling and beyond.

Authors:  Allen W Ho; Sarah L Gaffen
Journal:  Semin Immunopathol       Date:  2009-12-13       Impact factor: 9.623

7.  Cytokines induce small intestine and liver injury after renal ischemia or nephrectomy.

Authors:  Sang Won Park; Sean W C Chen; Mihwa Kim; Kevin M Brown; Jay K Kolls; Vivette D D'Agati; H Thomas Lee
Journal:  Lab Invest       Date:  2010-08-09       Impact factor: 5.662

Review 8.  Structure and signalling in the IL-17 receptor family.

Authors:  Sarah L Gaffen
Journal:  Nat Rev Immunol       Date:  2009-07-03       Impact factor: 53.106

Review 9.  An overview of IL-17 function and signaling.

Authors:  Sarah L Gaffen
Journal:  Cytokine       Date:  2008-08-12       Impact factor: 3.861

10.  Structural basis of receptor sharing by interleukin 17 cytokines.

Authors:  Lauren K Ely; Suzanne Fischer; K Christopher Garcia
Journal:  Nat Immunol       Date:  2009-10-18       Impact factor: 25.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.